Pipeline

Cardiovascular New Drug
Development Company-REDNVIA

Pipeline

Cardiovascular New Drug
Development Company-REDNVIA

Pipeline
RNV-1001

RNV-1001

CAVD
Unmet Medical Needs
Mode of Action
Patents & Publications

CAVD

CAVD causing heart valve dysfunction

What is Calcific Aortic Valve Disease?

CAVD is characterized by the progression of calcification in the aortic valve, leading to increased leaflet stiffness and consequently the development of Aortic Stenosis (AS).
On average, CAVD progresses into severe valve stenosis over a period of 5-10 years and is a representative heart disease of the ageing population.

Main Symptoms

Dyspnea(Difficulty in breathing)

Chest pain

Fainting

In the early stages of CAVD, patients may be asymptomatic and thus feel no pain or discomfort. However, as the disease progresses, narrowing of the heart valve can cause chest pain, fainting, dyspnea, and even death.